Molecular mechanisms of clinical concentrating and diluting disorders

Progress in Brain Research

Volumn 170, Issue , 2008, Pages 539-550

  Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

aquaretics; hyponatremia; V2 receptor antagonists; vasopressin; water channels

Indexed keywords

AQUAPORIN 2;

DOWN REGULATION; GLUCOCORTICOSTEROID DEFICIENCY; HEART FAILURE; HUMAN; HYPOTHYROIDISM; KIDNEY CONCENTRATING CAPACITY; LIVER CIRRHOSIS; MINERALOCORTICOID DEFICIENCY; MOLECULAR MECHANICS; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; OSMOREGULATION; POLYDIPSIA; POLYURIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

ANIMALS; AQUAPORIN 2; ARGININE VASOPRESSIN; BLOOD VOLUME; FEMALE; HEART FAILURE; HOMEOSTASIS; HUMANS; HYPONATREMIA; LIVER CIRRHOSIS; MODELS, BIOLOGICAL; POLYURIA; PREGNANCY; PREGNANCY COMPLICATIONS; PRESSORECEPTORS; RECEPTORS, VASOPRESSIN; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; URINE; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 47549085919     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00441-X     Document Type: Review

References (41)

1. Agre P., Preston G.M., Smith B.L., Jung J.S., Raina S., Moon C., Guggino W.B., and Nielsen S. Aquaporin CHIP: the archetypal molecular water channel. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 265 (1993) F463-F476
2. Agus Z., and Goldberg M. Role of antidiuretic hormone in the abnormal water diuresis of anterior hypopituitarism in man. J. Clin. Invest. 50 7 (1971) 1478-1489
3. Asahina Y., Izumi N., Enomoto N., Sasaki S., Fushimi K., Marumo F., and Sato C. Increased gene expression of water channel in cirrhotic rat kidneys. Hepatology 21 (1995) 169-173
4. Berl T., Cadnapaphornchai P., Harbottle J.A., and Schrier R.W. Mechanism of suppression of vasopressin during alpha-adrenergic stimulation with norepinephrine. J. Clin. Invest. 53 (1974) 219-227
5. Berl T., Cadnapaphornchai P., Harbottle J.A., and Schrier R.W. Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol. J. Clin. Invest. 53 (1974) 857-867
6. Bichet D.G. Lithium, cyclic AMP signaling, A-kinase anchoring proteins, and aquaporin-2. J. Am. Soc. Nephrol. 17 4 (2006) 920-922
7. Bichet D., Szatalowicz V., Chaimovitz C., and Schrier R.W. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann. Intern. Med. 96 (1982) 413-417
8. Buemi M., D'Anna R., DiPasquale G., Di Pasquali G., Flocceri F., Ruello A., Aloisi C., Leonardi I., Frisina N., and Corica F. Urinary excretion of aquaporin-2 water channel during pregnancy. Cell. Physiol. Biochem. 11 (2001) 203-208
9. Cadnapaphornchai M., Kim Y.-W., Gurevich A., Summer S., Falk S., and Schrier R.W. Urinary concentrating defect in hypothyroid rats: role of sodium, potassium, 2-chloride cotransporter and aquaporins. J. Am. Soc. Nephrol. 14 3 (2003) 566-574
10. Cadnapaphornchai M.A., Summer S., Falk S., Thurman J., Knepper M., and Schrier R.W. Effect of primary polydipsia on aquaporin and sodium transporter abundance. Am. J. Physiol. Renal Physiol. 285 (2003) F965-F97l
11. Chapman A.B., Abraham W.T., Zamudio S., Coffin C., Merouani A., Young D., Johnson A., Osorio F., Goldberg C., Moore L.G., Dahms T., and Schrier R.W. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 54 (1998) 2056-2063
12. Chen Y.-C., Cadnapaphomchai M.A., Summer S., Falk S., Li C., Wang W., and Schrier R.W. Molecular mechanisms of impaired urinary concentrating ability in glucocorticoid-deficient rats. J. Am. Soc. Nephrol. 16 (2005) 2864-2871
13. Chen Y.-C., Cadnapaphornchai M.A., Yang J., Summer S., Falk S., Li C., Wang W., and Schrier R.W. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism. Am. J. Physiol. Renal Physiol. 289 (2005) F672-F678
14. deWardener H., and Herxheimer A. The effect of a high water intake on the kidney's ability to concentrate urine in man. J. Physiol. 139 (1957) 42-52
15. Dunn F.L., Brennan T.J., and Nelson A.E. The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J. Clin. Invest. 52 (1973) 3212-3219
16. Du Vigneaud V., Gish D.T., and Katsoyannis P.G. A synthetic preparation possessing biological properties associated with arginine vasopressin. J. Am. Chem. Soc. 76 (1954) 4751-4752
17. Fushimi K., Uchida S., Hara K., Hirata Y., Marumo F., and Sasaki S. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 361 (1993) 549-552
18. Gerbes A.L., Gulerg V., Gines P., Decauz G., Gross P., Gandjini H., Dijan J., and VPA Study Group. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 124 (2003) 933-939
19. Gheorghiade M., Gattis W.A., O'Connor C.M., Adams Jr. K.F., Elkayam U., Barbagelata A., Ghali J.K., Benza R.L., McGrew F.A., Klapholz M., Ouyang J., Orlandi C., and Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291 (2004) 1963-1971
20. Gines A., Escorsell A., Gines P., Salo J., Jimenez W., Inglada L., Navasa M., Claria J., Rimola A., Arroyo V., et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105 (1993) 229-236
21. Ishikawa S., and Schrier R.W. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int. 22 (1982) 587-593
22. Lee W., and Packer M. Prognostic importance of serum concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 73 (1986) 257-267
23. Martin P.Y., Abraham W.T., Xu L., Olson B.R., Oren R.M., Ohara M., and Schrier R.W. Selective V2 receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J. Am. Soc. Nephrol. 10 (1999) 2165-2170
24. Nielsen S. Renal aquaporins: an overview. BJU Int. 90 Suppl. 3 (2002) 1-6
25. Nielsen S., Terris J., Andersen D., Ecelbarger C., Frokiaer J., Jonassen T., Marples D., Knepper M.A., and Petersen J.S. Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5450-5455
26. Ohara M., Cadnapaphornchai M.A., Summer S., Falk S., Yang J., Togawa T., and Schrier R.W. Effect of mineralocorticoid deficiency on ion and urea transporters and aquaporin water channels in the rat. Biochem. Biophys. Res. Commun. 299 (2002) 285-290
27. Ohara M., Martin P.-Y., Xu D.-L., St. John J., Pattison T., Kim J., and Schrier R.W. Upregulation of aquaporin 2 water channel expression in pregnant rats. J. Clin. Invest. 101 (1998) 1076-1083
28. Preston G.M., Carooll T.P., Guggino W.B., and Agre P. Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science 17 (1992) 385-387
29. Sands J., and Bichet D. Nephrogenic diabetes insipidus. Ann. Intern. Med. 144 (2006) 186-194
30. Schrier R.W. Body water homeostasis: clinical disorders of urinary dilution and concentration. J. Am. Soc. Nephrol. 17 7 (2006) 1820-1832
31. Schrier R.W. The sea within us: disorders of body water homeostasis. Curr. Opin. Invest. Drugs 8 4 (2007) 304-311
32. Schrier R.W., and Berl T. Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J. Clin. Invest. 51 (1972) 2613-2620
33. Schrier R.W., and Berl T. Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion. J. Clin. Invest. 52 (1974) 502-511
34. Schrier R.W., Berl T., and Anderson R.J. Osmotic and non-osmotic control of vasopressin release. Am. J. Physiol. 236 (1979) F321-F322
35. Schrier R.W., Gross P., Gheorghiade M., Berl T., Verbalis J.G., Czerwiec F.S., Orlandi C., and for the SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355 20 (2006) 2099-2112
36. Schrier R.W., Lieberman R.A., and Ufferman R.C. Mechanism of antidiuretic effect of beta adrenergic stimulation. J. Clin. Invest. 51 (1972) 97-111
37. Skowsky W.R., and Kikuchi T.A. The role of vasopressin in the impaired water excretion of myxedema. Am. J. Med. 64 (1978) 613-621
38. Szatalowicz V., Arnold P., Chaimovitz C., Bichet D., and Schrier R.W. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N. Engl. J. Med. 305 (1981) 263-266
39. Verney E.B. The antidiuretic hormone and the factors which determine its release. Proc. R. Soc. Lond. B Biol. Sci. 135 (1947) 27-106
40. Wang W., Li C., Summer S.N., Falk S., Cadnapaphornchai M.A., Chen Y.C., and Schrier R.W. Molecular analysis of impaired urinary diluting capacity in glucocorticoid deficiency. Am. J. Physiol. Renal Physiol. 290 (2006) F1135-F1142
41. Xu D., Martin P.-Y., Ohara M., St. John J., Pattison T., Meng X., Morris K., Kim J.K., and Schrier R.W. Upregulation of aquaporin-2 water channel expression in chronic heart failure. J. Clin. Invest. 99 (1997) 1500-1505